Keswani Sanjay Chandru 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Keswani Sanjay Chandru
Chief Medical Officer
Transactions
- Award
Stock Option
2025-06-02+70,101→ 70,101 totalExercise: $124.56Exp: 2035-06-02→ Common Stock (70,101 underlying) - Award
Restricted Stock Unit
2025-06-02+12,846→ 12,846 totalExercise: $0.00→ Common Stock (12,846 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.
- [F2]The Restricted Stock Units will vest annually at 25% of the units vesting on each of June 2, 2026, June 2, 2027, June 2, 2028, and June 2, 2029.
- [F3]Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on June 2, 2026 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter.